Results 81 to 90 of about 209,031 (375)
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022 Background Cardiac implantable electronic devices (CIEDs) include pacemakers, cardioverter defibrillators, and resynchronization therapy. This study aimed to assess CIED implantation and outcomes by sex and indication.
Kasun De Silva +8 more
doaj +1 more source
Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience. [PDF]
, 2014 AIMS: There are limited and contradictory data on the effects of CRT with implantable cardioverter defibrillator (CRT-D) on mortality as compared with CRT with pacemaker (CRT-P).
Becker Dávid +10 more
core +2 more sources
Comorbidities and clinical response to cardiac resynchronization therapy: Patient‐level meta‐analysis from eight clinical trials [PDF]
, 2023 Marat Fudim +14 more
openalex +1 more source
Imaging Cardiac Resynchronization Therapy
JACC: Cardiovascular Imaging, 2009 Although a prognostic benefit has been shown from cardiac resynchronization therapy, questions are often directed toward the prediction of symptomatic or functional benefit. Recent multicenter trials have shown the pitfalls of current mechanical markers of left ventricular synchrony, but these negative trial results have not marked the conclusion of ...
Abraham, Theodore +6 more
openaire +4 more sources
ESC Heart Failure, Volume 12, Issue 2, Page 980-997, April 2025.Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler +8 more
wiley +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018 Background Experimental evidence indicates that left ventricular (LV) apical pacing is hemodynamically superior to nonapical LV pacing. Some studies have shown that an LV apical lead position is unfavorable in cardiac resynchronization therapy. We sought
Francisco Leyva +10 more
doaj +1 more source
Left Ventricular Pacing In Patients With Congestive Heart Failure [PDF]
, 2006 Cardiac resynchronisation therapy (CRT) using biventricular (BIV) pacing has proved its effectiveness to correct myocardial asynchrony and improve clinical status of patients with severe congestive heart failure (CHF) and widened QRS. Despite a different
Etienne, Yves +2 more
core +2 more sources
Autonomic regulation therapy to enhance myocardial function in heart failure patients: the ANTHEM-HFpEF study. [PDF]
, 2017 BackgroundApproximately half of the patients presenting with new-onset heart failure (HF) have HF with preserved left ventricular ejection fraction (HFpEF) and HF with mid-range left ventricular ejection fraction (HFmrEF).
Amurthur, Badri +8 more
core +1 more source
Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysis [PDF]
, 2023 Emily P. Zeitler +13 more
openalex +1 more source
Circulation: Arrhythmia and Electrophysiology, 2019 Background: Cardiac resynchronization therapy (CRT) is an established therapy for patients with cardiomyopathy, left bundle branch block, and heart failure. His bundle pacing (HBP) may also improve clinical outcomes by narrowing QRS duration.
P. Vijayaraman +3 more
semanticscholar +1 more source